Shan S - Search Results

1

Regulation of Serine-Threonine Kinase Akt Activation by NAD⁺-Dependent Deacetylase SIRT7.

Yu J, Qin B, Wu F, Qin S, Nowsheen S, Shan S, Zayas J, Pei H, Lou Z, Wang L. Yu J, et al. Among authors: shan s. Cell Rep. 2017 Jan 31;18(5):1229-1240. doi: 10.1016/j.celrep.2017.01.009. Cell Rep. 2017. PMID: 28147277 Free PMC article.

2

The stimulatory activity of plasma in patients with advanced non-small cell lung cancer requires TLR-stimulating nucleic acid immunoglobulin complexes and discriminates responsiveness to chemotherapy.

Xu Z, Wu F, Wang C, Liu X, Kang B, Shan S, Gu X, Wang K, Ren T. Xu Z, et al. Among authors: shan s. Cancer Cell Int. 2014 Aug 12;14:80. doi: 10.1186/s12935-014-0080-1. eCollection 2014. Cancer Cell Int. 2014. PMID: 25788863 Free PMC article.

3

Clinical characteristics and survival of lung cancer patients associated with multiple primary malignancies.

Shan S, She J, Xue ZQ, Su CX, Ren SX, Wu FY. Shan S, et al. PLoS One. 2017 Sep 28;12(9):e0185485. doi: 10.1371/journal.pone.0185485. eCollection 2017. PLoS One. 2017. PMID: 28957405 Free PMC article.

4

Heterogeneous expression of ACE2, TMPRSS2, and FURIN at single-cell resolution in advanced non-small cell lung cancer.

Liu Z, Gu X, Li Z, Shan S, Wu F, Ren T. Liu Z, et al. Among authors: shan s. J Cancer Res Clin Oncol. 2023 Jul;149(7):3563-3573. doi: 10.1007/s00432-022-04253-1. Epub 2022 Aug 12. J Cancer Res Clin Oncol. 2023. PMID: 35960376 Free PMC article.

5

Mitophagy bridges DNA sensing with metabolic adaption to expand lung cancer stem-like cells.

Liu Z, Shan S, Yuan Z, Wu F, Zheng M, Wang Y, Gui J, Xu W, Wang C, Ren T, Wen Z. Liu Z, et al. Among authors: shan s. EMBO Rep. 2023 Feb 6;24(2):e54006. doi: 10.15252/embr.202154006. Epub 2022 Nov 23. EMBO Rep. 2023. PMID: 36416244 Free PMC article.

6

LncRNA-DANCR contributes to lung adenocarcinoma progression by sponging miR-496 to modulate mTOR expression.

Lu QC, Rui ZH, Guo ZL, Xie W, Shan S, Ren T. Lu QC, et al. Among authors: shan s. J Cell Mol Med. 2018 Mar;22(3):1527-1537. doi: 10.1111/jcmm.13420. Epub 2017 Dec 20. J Cell Mol Med. 2018. PMID: 29266795 Free PMC article.

7

[LB100 reverses the acquired resistance to gefitinib in lung adenocarcinoma cells with EGFR mutation].

Shan S, Wang YD, Ren T. Shan S, et al. Zhonghua Yi Xue Za Zhi. 2016 Nov 15;96(42):3398-3402. doi: 10.3760/cma.j.issn.0376-2491.2016.42.009. Zhonghua Yi Xue Za Zhi. 2016. PMID: 27866533 Chinese.

8

Isovalerylspiramycin I suppresses non-small cell lung carcinoma growth through ROS-mediated inhibition of PI3K/AKT signaling pathway.

Liu Z, Huang M, Hong Y, Wang S, Xu Y, Zhong C, Zhang J, Zhuang Z, Shan S, Ren T. Liu Z, et al. Among authors: shan s. Int J Biol Sci. 2022 May 21;18(9):3714-3730. doi: 10.7150/ijbs.69989. eCollection 2022. Int J Biol Sci. 2022. PMID: 35813464 Free PMC article.

9

miR-145 and miR-497 suppress TGF-β-induced epithelial-mesenchymal transition of non-small cell lung cancer by targeting MTDH.

Yin Q, Han Y, Zhu D, Li Z, Shan S, Jin W, Lu Q, Ren T. Yin Q, et al. Among authors: shan s. Cancer Cell Int. 2018 Jul 27;18:105. doi: 10.1186/s12935-018-0601-4. eCollection 2018. Cancer Cell Int. 2018. PMID: 30065618 Free PMC article.

10

MicroRNA-125b promotes tumor metastasis through targeting tumor protein 53-induced nuclear protein 1 in patients with non-small-cell lung cancer.

Li Q, Han Y, Wang C, Shan S, Wang Y, Zhang J, Ren T. Li Q, et al. Among authors: shan s. Cancer Cell Int. 2015 Sep 17;15:84. doi: 10.1186/s12935-015-0233-x. eCollection 2015. Cancer Cell Int. 2015. PMID: 26388699 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,635 results

Search Page

Filters